51 related articles for article (PubMed ID: 38214606)
1. Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: A review.
Liu S; Miao M; Kang L
Medicine (Baltimore); 2023 Jan; 102(2):e32625. PubMed ID: 36637946
[TBL] [Abstract][Full Text] [Related]
2. TRIM proteins in hepatocellular carcinoma.
Lu K; Pan Y; Huang Z; Liang H; Ding ZY; Zhang B
J Biomed Sci; 2022 Sep; 29(1):69. PubMed ID: 36100865
[TBL] [Abstract][Full Text] [Related]
3. RBCK1 overexpression is associated with immune cell infiltration and poor prognosis in hepatocellular carcinoma.
Yu J; Liu T; Liu M; Jin H; Wei Z
Aging (Albany NY); 2024 Jan; 16(1):538-549. PubMed ID: 38214606
[TBL] [Abstract][Full Text] [Related]
4. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced degradation of PICK1 by RBCK1 promotes the proliferation of nasopharyngeal carcinoma cells.
Zhang Y; Lu Y; Xu Y; Le Z; Liu Y; Tu W; Liu Y
Life Sci; 2023 May; 321():121594. PubMed ID: 36934971
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1.
Wang G; Zhuang Z; Shen S; Yang F; Jiang Z; Liu Z; Wang T; Hua L
Hum Cell; 2022 May; 35(3):896-908. PubMed ID: 35174471
[TBL] [Abstract][Full Text] [Related]
7. Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3.
Zhang M; Tian Y; Wang RP; Gao D; Zhang Y; Diao FC; Chen DY; Zhai ZH; Shu HB
Cell Res; 2008 Nov; 18(11):1096-104. PubMed ID: 18711448
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-α, RBCK1, and protein kinase C β 1 cooperate to regulate estrogen receptor-α gene expression.
Gustafsson Sheppard N; Heldring N; Dahlman-Wright K
J Mol Endocrinol; 2012 Dec; 49(3):277-87. PubMed ID: 23042805
[TBL] [Abstract][Full Text] [Related]
9. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc.
Lei X; Hu X; Lu Q; Yao Y; Sun W; Ma Q; Huang D; Xu Q
Biochem Biophys Res Commun; 2023 Jan; 638():210-218. PubMed ID: 36481361
[TBL] [Abstract][Full Text] [Related]
10. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest.
Szklarczyk D; Kirsch R; Koutrouli M; Nastou K; Mehryary F; Hachilif R; Gable AL; Fang T; Doncheva NT; Pyysalo S; Bork P; Jensen LJ; von Mering C
Nucleic Acids Res; 2023 Jan; 51(D1):D638-D646. PubMed ID: 36370105
[TBL] [Abstract][Full Text] [Related]
11. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T
Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma.
Vogel A; Meyer T; Sapisochin G; Salem R; Saborowski A
Lancet; 2022 Oct; 400(10360):1345-1362. PubMed ID: 36084663
[TBL] [Abstract][Full Text] [Related]
13. RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31.
Chen X; Ye Q; Zhao W; Chi X; Xie C; Wang X
Cell Death Discov; 2022 Jul; 8(1):334. PubMed ID: 35869046
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment.
Lim JTC; Kwang LG; Ho NCW; Toh CCM; Too NSH; Hooi L; Benoukraf T; Chow PK; Dan YY; Chow EK; Toh TB; Fong ELS
Biomaterials; 2022 May; 284():121527. PubMed ID: 35483200
[TBL] [Abstract][Full Text] [Related]
15. The E3 ubiquitin ligase RBCK1 promotes the invasion and metastasis of hepatocellular carcinoma by destroying the PPARγ/PGC1α complex.
Xu Z; Shao J; Zheng C; Cai J; Li B; Peng X; Chen L; Liu T
Am J Cancer Res; 2022; 12(3):1372-1392. PubMed ID: 35411229
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
